| | | | | Préparation | Taille des prés. | PEF | PP | QP | CQ | Composition | Titulaire de l'aut. | Cat. | | | | |
---|
|
février 2010 - 78 Spécialités |
|
L | | IPro | | | Ondansetron Labatec, 4mg/2ml | 5 1 ampoule(s) à 2 ml | 30.90 | 50.00 | 10% | | Concentré pour perfusion: Ondansetronum 4mg / 2ml | Labatec Pharma SA | B / LS / SG | FB | | G |  |
L | | IPro | | | Ondansetron Labatec, 8mg/4ml | 5 1 ampoule(s) à 4 ml | 57.55 | 79.00 | 10% | | Concentré pour perfusion: Ondansetronum 8mg / 4ml | Labatec Pharma SA | B / LS / SG | FB | | G |  |
L | | IPro | | | Ceftriaxon Labatec 2 g i.v. | 2 g | 9.90 | 27.20 | 10% | | Substance sèche: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / LS / SG | FB | | G |  |
L | | IPro | | | Ceftriaxon Labatec 2 g i.v. | 10 x 2 g | 84.15 | 107.95 | 10% | | Substance sèche: Ceftriaxonum 2000 mg | Labatec Pharma SA | A / LS / SG | FB | | G |  |
| | IPro | | | Vancomycin Labatec 500 mg | 500 mg | 10.89 | 28.25 | 10% | | Substance sèche: Vancomycinum 500 mg | Labatec Pharma SA | A / LS / SG | FB | | G |  |
L | | IPro | | | Vancomycin Labatec 500 mg | 10 x 500 mg | 108.85 | 134.80 | 10% | | Substance sèche: Vancomycinum 500 mg | Labatec Pharma SA | A / LS / SG | FB | | G |  |
| | IPro | | | Vancomycin Labatec 1 g | 1 g | 21.78 | 40.10 | 10% | | Substance sèche: Vancomycinum 1 g | Labatec Pharma SA | A / LS / SG | FB | | G |  |
L | | IPro | | | Vancomycin Labatec 1 g | 10 x 1 g | 217.80 | 253.30 | 10% | | Substance sèche: Vancomycinum 1 g | Labatec Pharma SA | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Cefuroxim Spirig HC 250 mg | 14 Comprimé(s) | 9.15 | 26.35 | 10% | | Comprimés filmés: Cefuroximum 250 mg | Spirig HealthCare AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Cefuroxim Spirig HC 500 mg | 14 Comprimé(s) | 15.00 | 32.75 | 10% | | Comprimés filmés: Cefuroximum 500 mg | Spirig HealthCare AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Irbesartan Sandoz 150 | 28 Comprimé(s) | 12.33 | 29.80 | 10% | | Comprimés filmés: Irbesartanum 150 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Irbesartan Sandoz 150 | 98 Comprimé(s) | 39.79 | 59.70 | 10% | | Comprimés filmés: Irbesartanum 150 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Irbesartan Sandoz 300 | 28 Comprimé(s) | 16.66 | 34.55 | 10% | | Comprimés filmés: Irbesartanum 300 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Irbesartan Sandoz 300 | 98 Comprimé(s) | 57.50 | 78.95 | 10% | | Comprimés filmés: Irbesartanum 300 mg | Sandoz Pharmaceuticals AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Levofloxacin-Mepha Teva 250 mg | 5 | 6.53 | 16.35 | 10% | | Comprimés filmés: Levofloxacinum 250 mg | Mepha Pharma AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Levofloxacin-Mepha Teva 250 mg | 7 | 8.61 | 25.80 | 10% | | Comprimés filmés: Levofloxacinum 250 mg | Mepha Pharma AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Levofloxacin-Mepha Teva 250 mg | 10 | 11.52 | 28.95 | 10% | | Comprimés filmés: Levofloxacinum 250 mg | Mepha Pharma AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Levofloxacin-Mepha Teva 500 mg | 5 | 9.83 | 27.10 | 10% | | Comprimés filmés: Levofloxacinum 500 mg | Mepha Pharma AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Levofloxacin-Mepha Teva 500 mg | 7 | 12.93 | 30.50 | 10% | | Comprimés filmés: Levofloxacinum 500 mg | Mepha Pharma AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Levofloxacin-Mepha Teva 500 mg | 10 | 17.33 | 35.25 | 10% | | Comprimés filmés: Levofloxacinum 500 mg | Mepha Pharma AG | A / LS / SG | FB | | G |  |
| | IPro | IPat | | Nebivolol Spirig HC | 28 Comprimé(s) | 4.83 | 14.50 | 10% | | Comprimés: Nebivololum 5 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Nebivolol Spirig HC | 56 Comprimé(s) | 8.50 | 25.65 | 10% | | Comprimés: Nebivololum 5 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Nebivolol Spirig HC | 98 Comprimé(s) | 14.20 | 31.85 | 10% | | Comprimés: Nebivololum 5 mg | Spirig HealthCare AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Pramipexol-Mepha 0.125 mg | 30 | 4.98 | 14.65 | 10% | | Comprimés: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Pramipexol-Mepha 0.25 mg | 30 | 11.82 | 29.25 | 10% | | Comprimés: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Pramipexol-Mepha 0.25 mg | 100 | 33.33 | 52.65 | 10% | | Comprimés: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Pramipexol-Mepha 0.5 mg | 100 | 44.80 | 65.15 | 10% | | Comprimés: Pramipexoli Dihydrochloridum Monohydricum | Mepha Pharma AG | B / LS / SG | FB | | G |  |
| | IPro | IPat | | Pramipexol-Mepha 1.0 mg | 100 | 114.50 | 140.95 | 10% | | Comprimés: Pramipexoli Dihydrochloridum Monohydricum 1 mg | Mepha Pharma AG | B / LS / SG | FB | | G |  |
L | | IPro | | | Ceftriaxon Labatec 1 g i.v./i.m. | 1 g | 6.15 | 15.90 | 10% | | poudre pour solution injectable: Ceftriaxonum 1000 mg | Labatec Pharma SA | A / LS / SG | FB | | G |  |
L | | IPro | | | Ceftriaxon Labatec 1 g i.v./i.m. | 10 x 1 g | 52.25 | 73.25 | 10% | | poudre pour solution injectable: Ceftriaxonum 1000 mg | Labatec Pharma SA | A / LS / SG | FB | | G |  |
L | | IPro | | V/S | Octagam 10 % | flacon(s) | 132.67 | 160.70 | 10% | | Solution injectable: Proteina 100 mg/ml | Octapharma AG | B / LS | FB | | G |  |
L | | IPro | | V/S | Octagam 10 % | flacon(s) | 331.67 | 377.15 | 10% | | Solution injectable: Proteina 100 mg/ml | Octapharma AG | B / LS | FB | | G |  |
L | | IPro | | V/S | Octagam 10 % | flacon(s) | 663.33 | 737.85 | 10% | | Solution injectable: Proteina 100 mg/ml | Octapharma AG | B / LS | FB | | G |  |
L | | IPro | | V/S | Octagam 10 % | flacon(s) | 1326.67 | 1459.25 | 10% | | Solution injectable: Proteina 100 mg/ml | Octapharma AG | B / LS | FB | | G |  |
L | | IPro | | V/S | Octagam 10 % | | 1990.00 | 2180.65 | 10% | | Solution injectable: Proteina 100 mg/ml | Octapharma AG | B / LS | FB | | G |  |
L | | IPro | | | Zarzio 30 MU/0.5 ml | 5 seringue(s) | 293.98 | 335.45 | 10% | | Solution injectable en seringue prête à l'emploi: Filgrastimum | Sandoz Pharmaceuticals AG | A / LS | FB | | G |  |
L | | IPro | | | Zarzio 48 MU/0.5 ml | 5 seringue(s) | 413.81 | 465.50 | 10% | | Solution injectable en seringue prête à l'emploi: Filgrastimum | Sandoz Pharmaceuticals AG | A / LS | FB | | G |  |
| | IPro | | | Lucrin Depot 6 Monate | seringue(s) | 930.57 | 1028.45 | 10% | | Préparation injectable: Leuprorelini Acetas 30 mg | AbbVie AG | A / LS | FB | | G |  |
| | IPro | IPat | Ph | Hyperiplant Rx | 40 Comprimé(s) | 14.99 | 32.70 | 10% | | Comprimés filmés: Hyperici Herbae Extractum Methanolicum Siccum 600 mg | Schwabe Pharma AG | B / LS | FB | | G |  |
| | IPro | IPat | Ph | Hyperiplant Rx | 100 Comprimé(s) | 39.05 | 58.90 | 10% | | Comprimés filmés: Hyperici Herbae Extractum Methanolicum Siccum 600 mg | Schwabe Pharma AG | B / LS | FB | | G |  |
L | | IPro | IPat | | Onglyza 2.5 mg | 28 Comprimé(s) | 27.12 | 45.90 | 10% | | Comprimés filmés: Saxagliptinum 2.5 mg | AstraZeneca AG | B / LS | FB | | G |  |
L | | IPro | IPat | | Onglyza 2.5 mg | 98 Comprimé(s) | 92.37 | 116.85 | 10% | | Comprimés filmés: Saxagliptinum 2.5 mg | AstraZeneca AG | ● B / LS | FB | | G |  |
L | | IPro | IPat | | Onglyza 5 mg | 28 Comprimé(s) | 27.12 | 45.90 | 10% | | Comprimés filmés: Saxagliptinum 5 mg | AstraZeneca AG | B / LS | FB | | G |  |
L | | IPro | IPat | | Onglyza 5 mg | 98 Comprimé(s) | 92.37 | 116.85 | 10% | | Comprimés filmés: Saxagliptinum 5 mg | AstraZeneca AG | B / LS | FB | | G |  |
| | IPro | | | Firmagon 80 mg | Set(s) | 119.57 | 146.45 | 10% | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension (Lösungsmittel in Fertigspritze): Degarelixum 80 mg | Ferring AG | A / LS | FB | | G |  |
| | IPro | | | Firmagon 120 mg | Set(s) | 245.66 | 283.60 | 10% | | Pulver und Lösungsmittel zur Herstellung einer Injektionssuspension (Lösungsmittel in Fertigspritze): Degarelixum 120 mg | Ferring AG | A / LS | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 10 x 2 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 10 x 5 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 50 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 10 x 10 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 100 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 100 x 2 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 100 x 5 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 10 x 50 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 100 x 10 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Aqua ad iniectabilia Amino | 10 x 100 ml | DDP | DDP | N.O. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Glucose Amino 5% | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Glucosum 50 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Glucose Amino 5% | 100 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Glucosum 50 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Glucose Amino 10% | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Glucosum 100 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Glucose Amino 20% | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Glucosum 200 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Glucose Amino 40% | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Glucosum 400 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Glucose Amino 40% | 100 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Glucosum 400 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 10 x 2 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 10 x 5 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 50 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 10 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 100 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 100 x 2 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 100 x 5 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 10 x 50 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 100 x 10 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum 0,9% Amino | 10 x 100 ml | DDP | DDP | N.O. | | Solution injectable: Natrii Chloridum 9 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Patentblau V Guerbet | 5 1 ampoule(s) à 2 ml | DDP | DDP | N.O. | | Solution injectable: Caeruleum Protectum V 25 mg/ml | Guerbet AG | B | FB | | G |  |
| | IPro | | | Natrium chloratum Amino 10% | 10 x 10 ml | DDP | DDP | N.O. | | Konzentrat für Infusionslösungen: Natrii Chloridum 100 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Natrium chloratum Amino 20% | 10 x 10 ml | DDP | DDP | N.O. | | Konzentrat für Infusionslösungen: Natrii Chloridum 200 mg/ml | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | B | FB | | G |  |
| | IPro | | | Ceftriaxon Labatec 250 mg i.m. | 10 x 250 mg | DDP | DDP | N.O. | | poudre pour solution injectable: Ceftriaxonum 250 mg | Labatec Pharma SA | A | FB | | G |  |
| | IPro | | | Ceftriaxon Labatec 500 mg i.v. | 10 x 500 mg | DDP | DDP | N.O. | | poudre pour solution injectable: Ceftriaxonum 500 mg | Labatec Pharma SA | A | FB | | G |  |
| | IPro | | | Teicoplanin Labatec 200 mg | 200 mg | DDP | DDP | N.O. | | poudre pour solution injectable/pour perfusion: Teicoplaninum 200 mg | Labatec Pharma SA | A | FB | | G |  |